医学
支气管扩张
囊性纤维化
危害
重症监护医学
内科学
肺
政治学
法学
作者
James D. Chalmers,Mark L. Metersky,J. Feliciano,Carlos Fernández,A. Teper,A. Maes,Mariam Hassan,Anjan Chatterjee
出处
期刊：ERJ Open Research
[European Respiratory Society]
日期：2023-03-23
卷期号：9 (3): 00695-2022
被引量：6
标识
DOI：10.1183/23120541.00695-2022
摘要
Brensocatib is a novel anti-inflammatory therapy in development for bronchiectasis treatment. Phase 2 WILLOW trial data demonstrate a low number needed to treat and negative number needed to harm, suggesting a favourable benefit-risk profile. https://bit.ly/3SbisW3.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
bc
归尘
pluto
冰魂
昏睡的蟠桃
jenningseastera
Auston_zhong
遇上就这样吧
back you up
不倦
顺心香菇
科研小民工
1111
乐乐
sutharsons
我是站长才怪
勤劳的忆寒
平常的毛豆
rye227
皖公网安备34019202002308
